Immediate Impact

3 by Nobel laureates 8 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Direct radical functionalization of native sugars
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Antonella Perotti being referenced

Phase Ib study of the anti-TGF-β monoclonal antibody (mAb) NIS793 combined with spartalizumab (PDR001), a PD-1 inhibitor, in patients (pts) with advanced solid tumors.
2021
Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours
2018

Author Peers

Author Last Decade Papers Cites
Antonella Perotti 309 227 97 140 24 574
Ling‐Yuh Huw 259 250 139 79 26 628
Christian R. De Potter 252 175 105 58 17 581
Andrew W. McFadden 149 356 79 198 18 631
M Morganti 224 208 68 66 19 503
Ana Teresa Amaral 200 302 140 235 19 604
Yongkui Lu 340 216 140 252 19 632
Sharareh Siamakpour‐Reihani 142 241 164 80 25 515
Reinaldo Chacón 297 164 150 89 24 569
Tomoyuki Aoyama 217 183 108 298 38 630
Shih-Chen Yu 141 213 116 251 15 576

All Works

Loading papers...

Rankless by CCL
2026